Camber launches eltrombopag tablets and oral suspension
Through Camber’s copayment program, eligible patients may pay as little as $0 out-of-pocket. Visit Camber’s eltrombopag web page for full offer details.
Pharmacy
NPC names Dr. Kenneth Finegold as senior vice president of Research and Policy
He joins NPC’s team where he will apply his deep knowledge of the research and evidence used to support federal health policymaking to drive NPC’s policy-
NACDS applauds inclusion of Medicaid PBM reform in Reconciliation Bill
Long-overdue Medicaid PBM reforms would protect American taxpayers, patients, pharmacies.
NACDS observes Women’s Health Month and Mental Health Awareness Month
May campaign highlights NACDS members’ support of Nourish My Health.
Aetna, National Alliance for Care at Home and MissionCare Collective team to strengthen direct care workforce in Illinois, Louisiana and North Carolina
Aetna invests to improve access to home health care and support the direct care workforce.
New study challenges GLP-1 norms with strong results on a fraction of the usual dose
In one of the largest and longest real-world obesity studies to date, Embla tracked nearly 2,700 adults over 64 weeks and achieved 16.7% average weight loss using 66% less semaglutide than typical U.S. doses.
CVS Health reopens Hendersonville store destroyed by Hurricane Helene
The Hendersonville store is now open to serve customers with extended hours and a renewed focus on providing accessible, high-quality healthcare services.
Dr. Scott Furness joins CHPA’s senior management team
Dr. Furness joins CHPA after over 25 years at the FDA, where he held several leadership positions.
Trump signs executive order that aims to slash drug prices
The order gives drugmakers price targets in the next 30 days, and will take further action to lower prices if those companies do not make "significant progress" towards those goals within six months of the order being signed.
Pharmacists should be clinical leaders with GLP-1s
By Betty Pio, Laura Bowen, Sarah Scolnic and Christi Rich
New study refutes clains that PBM's raise drug prices
Economic analysis reveals fundamental logical contradiction: No one would pay for services that increase costs.
NCPDP showcases innovation and collaboration at 2025 Annual Conference
Keynote speakers, industry insights, new Board appointments, and the Champion Award highlight NCPDP's ongoing leadership in advancing healthcare interoperability.
U.S. Drug spending up 10.2% in 2024, with weight loss drugs topping the list
Tariff concerns raise risk of shortages and higher costs.
RILA warns tariffs on pharma could hurt consumers
Industry warns of higher consumer costs, shortages, and unintended fallout from national security measures.
Global generic drugs market to reach $594.99 billion by 2031
The combination of patent cliffs, supportive policy environments, and increasing disease prevalence is creating strong growth momentum.
Lilly to expand collaboration with Purdue University
Will include a planned investment up to a $250 million to accelerate pharmaceutical innovation.